DOI: 10.1101/2020.10.16.343137
Funding statement: Algorithm development and image analysis for this study were partially supported by the National Institute on Aging (RF1AG051710, R21AG065942, R01AG031581 and P30AG19610), the National Library of Medicine, National Cancer Institute, the National Institute for Biomedical Imaging and Bioengineering (R01EB025032), and the Arizona Alzheimer Consortium. | Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DoD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
Annotated funders:
funder_name: National Institute on Aging
awards: award_ids: RF1AG051710
R21AG065942
R01AG031581
P30AG19610
funder_name: National Library of Medicine
funder_name: National Cancer Institute
funder_name: National Institute for Biomedical Imaging and Bioengineering
awards: award_ids: R01EB025032
funder_name: Arizona Alzheimer Consortium
funder_name: Alzheimer's Disease Neuroimaging Initiative (ADNI)
awards: award_ids: U01 AG024904
funder_name: DoD ADNI
awards: award_ids: W81XWH-12-2-0012
funder_name: Alzheimer's Association
funder_name: Alzheimer's Drug Discovery Foundation
funder_name: BioClinica, Inc.
funder_name: Biogen Idec Inc.
funder_name: Bristol-Myers Squibb Company
funder_name: Eisai Inc.
funder_name: Elan Pharmaceuticals, Inc.
funder_name: Eli Lilly and Company
funder_name: F. Hoffmann-La Roche Ltd
funder_name: Genentech, Inc.
funder_name: GE Healthcare
funder_name: Innogenetics, N.V.
funder_name: IXICO Ltd.
funder_name: Janssen Alzheimer Immunotherapy Research & Development, LLC.
funder_name: Johnson & Johnson Pharmaceutical Research & Development LLC.
funder_name: Medpace, Inc.
funder_name: Merck & Co., Inc.
funder_name: Meso Scale Diagnostics, LLC.
funder_name: NeuroRx Research
funder_name: Novartis Pharmaceuticals Corporation
funder_name: Pfizer Inc.
funder_name: Piramal Imaging
funder_name: Servier
funder_name: Synarc Inc.
funder_name: Takeda Pharmaceutical Company
funder_name: Canadian Institutes of Health Research
funder_name: Foundation for the National Institutes of Health